Buchumschlag

Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry

Early targeted antimicrobial therapy helps saving costs and prevents the spread of antimicrobial resistances including in Escherichia coli, the most frequent gram-negative bacterium causing sepsis. Therefore, rapid susceptibility testing represents the major prerequisite for knowledge-based successf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Grundt, Alexander (VerfasserIn) , Findeisen, Peter (VerfasserIn) , Miethke, Thomas (VerfasserIn) , Jäger, Evelyn (VerfasserIn) , Ahmad-Nejad, Parviz (VerfasserIn) , Neumaier, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 2012
In: Journal of clinical microbiology
Year: 2012, Jahrgang: 50, Heft: 5, Pages: 1727-1729
ISSN:1098-660X
DOI:10.1128/JCM.00047-12
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1128/JCM.00047-12
Verlag, Volltext: http://jcm.asm.org/content/early/2012/02/02/JCM.00047-12
Volltext
Verfasserangaben:A. Grundt, P. Findeisen, T. Miethke, E. Jäger, P. Ahmad-Nejad and M. Neumaier
Beschreibung
Zusammenfassung:Early targeted antimicrobial therapy helps saving costs and prevents the spread of antimicrobial resistances including in Escherichia coli, the most frequent gram-negative bacterium causing sepsis. Therefore, rapid susceptibility testing represents the major prerequisite for knowledge-based successful antimicrobial treatment. To accelerate testing for antibiotic susceptibility, we have developed a new mass spectrometry-based assay for antibiotic susceptibility testing (MAAST). For proof of principle we present an ampicillin susceptibility test for E.coli with a TAT of 90 minutes upon growth detection.
Beschreibung:Gesehen am 16.07.2018
Beschreibung:Online Resource
ISSN:1098-660X
DOI:10.1128/JCM.00047-12

Ähnliche Einträge